Lindsay McMullen's Contact Details

Lindsay McMullen's Company Details

NeuMoDx Molecular

Ann Arbor, MI, US • 100 - 249 Employees
Medical Equipment

The NeuMoDx Molecular systems are a family of scalable platforms that fully integrate the entire molecular diagnostic process from "sample to result." The NeuMoDx™ 288 and the NeuMoDx™ 96 Molecular systems are fully automated, continuous random-access analyzers that utilize proprietary NeuDry reagent technology, which integrates magnetic particle affinity capture and real time Polymerase Chain Reaction (PCR) chemistry in a multi-sample microfluidic cartridge. This technology, combined with a platform, uniquely incorporates robotics and microfluidics that result in higher throughput, improved performance, and increased efficiency by eliminating the waste associated with technologies that require reconstitution of lyophilized reagents.NeuMoDx Molecular has recently received FDA 510(k) clearance for its NeuMoDx™ GBS Assay for the detection of Group B Streptococcus (GBS) DNA in antepartum pregnant women and will continue development of tests to detect and monitor sexually transmitted and infectious diseases. Additionally, NeuMoDx Molecular offers a broad range of general purpose reagents and consumables for use by laboratorians in developing qualitative and quantitative Laboratory Developed Tests (LDTs) for use with the NeuMoDx™ Molecular Systems to detect and amplify DNA and RNA targets.Call 888-301-6639 or email info@neumodx.com.